Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,674.80
(
1.42%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
113.19
(
0.72%
)
Bitcoin
75,660.66
(
-0.15%
)
News Focus
News Focus
Post# of 118616
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

SidVicious

Send PM Follow Ignore
Followers 56
Posts 8449
Boards Moderated 0
Alias Born 05/14/2015

SidVicious

Re: AfricanTrader post# 82122

Sunday, 08/22/2021 12:47:22 PM

Sunday, August 22, 2021 12:47:22 PM

Post# of 118616
Many companies, including biotechs, have patents. Patents are a dime a dozen. Patents do not equate to revenue or even a product. With that, how many OTC biotechs with just a patent library have ever sold those patents for a big payday to any legitimate, well funded and established biotech or big pharma company?

FACTS are stubborn things

Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RGBP News
More RGBP News